IMC provided further evidence of a distinct immune phenotype in the high-SMIM25 group, with significantly higher CD4 and CD68 expression in the stromal region compared to the tumor region (p < 0.05; Figure 4F,G). The gene discussed is CD4; the disease is neoplasm.